M&A: BASF extends ProNova offer after only 67% sell; DSM confirms Fortitech buy
BASF has extended the bid period for its €650m offer to buy high-dose omega-3 specialist Pronova BioPharma, after only 67.2% of the Norwegian firm’s shareholders agreed to sell their stakes.